跳至主要内容
临床试验/CTRI/2018/03/012408
CTRI/2018/03/012408已完成未知

Effect of early treatment with Zoledronic acid in prevention of bone loss in spinal cord injury patients: a randomized prospective interventional study.

Dr Satyaranjan Sethi0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. SCI patients
  • 2. ASIA Impairment Scale A,B,C
  • 3. Age over 18years
  • 4. Less than 3months from date of trauma

排除标准

  • 1. Hypocalcaemia (Serum Calcium < 8.5mg %)
  • 2. Vitamin-D deficiency (Serum 25-hydroxy vitamin-D < 25nmol/L)
  • 3. Significant renal impairment (Creatinine clearance < 30ml/min)
  • 4. Any history of allergic reaction to bisphosphonates
  • 5. History of iritis, uveitis, psychiatric illness
  • 6. Female subjects who are pregnant, lactating or premenopausal women planning to conceive

研究者

发起方
Dr Satyaranjan Sethi

相似试验

Zoledronic acid injection prevents bone loss in... | 临床试验